Baris Boyraz Selected Research

taxane

4/2013

Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baris Boyraz Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 04/2013
3	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2013
2	Leiomyoma (Uterine Fibroids) 06/2022 - 03/2022
1	Leiomyomatosis 03/2022
1	COVID-19 01/2022
1	Persistent Infection 01/2022
1	Endometrial Stromal Sarcoma 01/2022
1	Glomus Tumor (Glomus Tumors) 01/2022
1	Leiomyosarcoma 01/2022
1	Carcinoma (Carcinomatosis) 09/2021
1	Myocarditis (Carditis) 01/2021
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 12/2015
1	Idiopathic Pulmonary Fibrosis 12/2015

Drug/Important Bio-Agent (IBA)

2	Fumarate Hydratase (Fumarase)IBA 06/2022 - 03/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 04/2013
1	S100 Proteins (S 100 Protein)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Cyclin D1IBA 01/2022
1	DesminIBA 01/2022
1	Thyroglobulin FDA Link 09/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	poly(A)-specific ribonucleaseIBA 12/2015
1	telomerase RNA (bTR)IBA 12/2015
1	Pharmaceutical PreparationsIBA 04/2013
1	Cytotoxins (Cytolysins)IBA 04/2013
1	Ado-Trastuzumab EmtansineIBA 04/2013
1	Lapatinib (GW572016)FDA Link 04/2013
1	taxaneIBA 04/2013
1	Trastuzumab (Herceptin)FDA Link 04/2013
1	ErbB Receptors (EGF Receptor)IBA 04/2013
1	Sulfides (Thioethers)IBA 04/2013
1	Maytansine (Maitansine)IBA 04/2013

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2013
1	Uterine Myomectomy 03/2022
1	Drug Therapy (Chemotherapy) 04/2013